🔥🐔 BizChicken 🐔🔥
Companies Similar to Zevra Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
KalVista Pharmaceuticals, Inc.
KVD001, sebetralstat, KVD824, Factor XIIa
Kal Vista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing small molecule protease inhibitors for diseases with unmet needs, including hereditary angioedema and diabetic macular edema.
About | About | Management | Directors | About | Contact | Careers | Careers | About | About | About | About | About | About | ESG | About | About | Careers | About | About
Symbol: KALV
Recent Price: $8.39
Industry: Biotechnology
CEO: Mr. Benjamin L. Palleiko
Sector: Healthcare
Employees: 150
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 857 999 0075
Leadership
- Albert Cha, Member of Board of Directors
- William (Bill) Fairey, Member of Board of Directors
- Benjamin L. Palleiko, Chief Executive Officer and Director
- Brian J. G. Pereira, Member of Board of Directors
- Nancy Stuart, Member of Board of Directors
- Pat Treanor, Member of Board of Directors
- Edward W. Unkart, Member of Board of Directors
Last updated: 2024-12-31
Protagonist Therapeutics, Inc.
rusfertide (PTG-300), PN-943, PN-235
Protagonist Therapeutics, Inc. is a biopharmaceutical company that focuses on the discovery and development of peptide-based therapeutic drugs for hematology, blood disorders, and inflammatory and immunomodulatory diseases.
Symbol: PTGX
Recent Price: $38.51
Industry: Biotechnology
CEO: Dr. Dinesh V. Patel Ph.D.
Sector: Healthcare
Employees: 125
Address: 7707 Gateway Boulevard, Newark, CA 94560-1160
Phone: 510 474 0170
Last updated: 2024-12-31
NRx Pharmaceuticals, Inc.
ZYESAMI, NRX-100, NRX-101
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.
Symbol: NRXP
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Jonathan C. Javitt M.D., M.P.H.
Sector: Healthcare
Employees: 2
Address: 1201 Orange Street, Wilmington, DE 19801
Phone: 484 254 6134
Last updated: 2024-12-31
Supernus Pharmaceuticals, Inc.
Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC
Supernus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases, including epilepsy, migraine, ADHD, and Parkinson's Disease.
Symbol: SUPN
Recent Price: $36.91
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Jack A. Khattar M.B.A.
Sector: Healthcare
Employees: 652
Address: 9715 Key West Avenue, Rockville, MD 20850
Phone: 301 838 2500
Last updated: 2024-12-31
Reneo Pharmaceuticals, Inc.
REN001
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.
About | About | About | Management | Directors | Contact | Contact | Careers | Careers | About | About | About
Symbol: RPHM
Recent Price: $18.20
Industry: Biotechnology
CEO: Mr. Gregory J. Flesher
Sector: Healthcare
Employees: 8
Address: 18575 Jamboree Road, Irvine, CA 92612
Phone: 619 733 3852
Last updated: 2024-12-31
Sarepta Therapeutics, Inc.
EXONDYS 51, VYONDYS 53, AMONDYS 45, SRP-5051, SRP-9001, SRP-9003
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-targeted therapeutics and gene therapies for rare diseases, including treatments for Duchenne muscular dystrophy.
Contact | About | Leadership | About | About | About | Locations | About | About | About | About
Symbol: SRPT
Recent Price: $121.19
Industry: Biotechnology
CEO: Mr. Douglas S. Ingram Esq.
Sector: Healthcare
Employees: 1314
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 274 4000
Leadership
- Douglas S. Ingram, President and Chief Executive Officer
- Bilal Arif, Executive Vice President, Chief Technical Operations Officer
- Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer
- Ryan E. Brown, JD, Executive Vice President, Chief General Counsel
- Ian M. Estepan, Executive Vice President, Chief Financial Officer
- Dallan Murray, Executive Vice President, Chief Customer Officer
- Alison Nasisi, Executive Vice President, Chief People Officer
- Louise R. Rodino-Klapac, PhD, Executive Vice President, Head of R&D, Chief Scientific Officer
- Will Tilton, Senior Vice President, Head of Strategy, Chief of Staff
- M. Kathleen Behrens, PhD, Chairwoman
- Richard J. Barry,
- Kathryn Boor, PhD,
- Michael Chambers,
- Deirdre Connelly,
- Stephen L. Mayo, PhD,
- Claude Nicaise, MD,
- Hans Wigzell, MD, PhD,
- John C. Martin, PhD (In Memoriam),
- Annemieke Aartsma-Rus, PhD,
- Carsten Bönnemann, MD,
- Joy Cavagnaro, PhD, DABT, Fellow ATS,
- Kay Davies, PhD, DBE FMedSci FRS,
- Steven Gray, PhD,
- Angela J. Russell, DPhil,
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Cara Therapeutics, Inc.
KORSUVA (difelikefalin)
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for pruritus and pain by targeting kappa opioid receptors. Their leading product, KORSUVA, is aimed at treating pruritus associated with chronic kidney disease in hemodialysis patients.
About | About | Management | Directors | About | Contact | ESG | Careers | Careers | About | About | About | About
Symbol: CARA
Recent Price: $0.35
Industry: Biotechnology
CEO: Mr. Christopher A. Posner
Sector: Healthcare
Employees: 55
Address: 4 Stamford Plaza, Stamford, CT 06902
Phone: 203 406 3700
Leadership
- Martin Vogelbaum, Chairman
- Christopher Posner, Chief Executive Officer, President, and Director
- Susan Shiff, Ph.D., Director
- Jeffrey L. Ives, Ph.D., Director
- Lisa von Moltke, M.D., Director
- Helen M. Boudreau, Director
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Kezar Life Sciences, Inc.
KZR-616
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics to address unmet needs in immune-mediated diseases and cancer in the United States.
About | About | About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Leadership | About | About | About | About | About | About | About | News | About | Careers | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: KZR
Recent Price: $6.82
Industry: Biotechnology
CEO: Dr. Christopher J. Kirk Ph.D.
Sector: Healthcare
Employees: 58
Address: 4000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 822 5600
Leadership
- Christopher Kirk, PhD, Chief Executive Officer, Co-Founder
- Marc Belsky, Chief Financial Officer
- Mark Schiller, Chief Legal Officer
- Neel K. Anand, DPhil, SVP, Research and Drug Discovery
- Zung To, SVP, Clinical Development
- Gitanjali Jain, SVP, Investor Relations and External Affairs
- Michelle Greenman, VP, Global Regulatory Affairs
- Jim Kirchner, PhD, VP, CMC and Supply Chain
- Andrew Basham, VP, Legal Affairs
- Dave Braggs, VP, Quality Assurance
- Pattie Chiang, SVP, Corporate Controller
- Tony Muchamuel, VP, Pharmacology & Toxicology
- Kiruthi Palaniswamy, PharmD, VP, Medical Affairs
- Mary Rogers, VP, Financial Planning & Analysis
- Joe Tedrick, VP, Human Resources
- Jinhai Wang, PhD, VP, Drug Metabolism & Pharmacokinetics
- John Fowler, Co-Founder
- Graham Cooper, Board Member, Beam Therapeutics, Former CFO, Receptos
- Franklin Berger, Founder
- Elizabeth Garner, MD, MPH, Chief Science Officer
- Michael Kauffman, MD, PhD, President, Chief Executive Officer, and Director
- Micki Klearman, MD, Former Group Medical Director
- Courtney Wallace, Venture Partner
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
Ultragenyx Pharmaceutical Inc.
Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.
Leadership | About | About | About
Symbol: RARE
Recent Price: $42.27
Industry: Biotechnology
CEO: Dr. Emil D. Kakkis M.D., Ph.D.
Sector: Healthcare
Employees: 1276
Address: 60 Leveroni Court, Novato, CA 94949
Phone: 415 483 8800
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Titan Pharmaceuticals, Inc.
Pro Neura
Titan Pharmaceuticals, Inc. is a pharmaceutical company developing therapeutics for chronic diseases utilizing the Pro Neura drug delivery platform. Its products include the Probuphine implant for opioid use disorder treatment, among other programs for chronic pruritus, opioid relapse prevention, HIV prevention, and contraception.
About | About | Leadership | Directors | About | Contact | Directors | Directors | Directors | Careers | About
Symbol: TTNP
Recent Price: $3.40
Industry: Biotechnology
CEO: Jennifer Kiernan
Sector: Healthcare
Employees: 4
Address: 400 Oyster Point Boulevard, South San Francisco, CA 94080-1958
Phone: 650 244 4990
Leadership
- Dato’ Seow Gim Shen, Chief Executive Officer and Chairman of the Board of Directors
- Avraham Ben-Tzvi, Founder
- Brynner Chiam, Vice President of Finance and Tax
- Firdauz Edmin Bin Mokhtar, Chief Executive Officer
- Francisco Osvaldo Flores García, Managing Partner
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Zevra Therapeutics, Inc.
KP1077, KP879
Zevra Therapeutics is a rare disease company focused on developing proprietary prodrugs using Ligand Activated Therapy to treat medical conditions such as ADHD, stimulant use disorder, and CNS rare diseases. Their lead candidates include KP1077 for idiopathic hypersomnia and KP879 for stimulant use disorder.
About | Contact | Careers | Careers | About | About | About | About | About | About | About | About | Leadership | Directors | About | Careers | Contact | Vision/Values | About
Symbol: ZVRA
Recent Price: $8.21
Industry: Biotechnology
CEO: Mr. Neil F. McFarlane
Sector: Healthcare
Employees: 65
Address: 1180 Celebration Boulevard, Celebration, FL 34747
Phone: 321 939 3416
Last updated: 2024-12-31
ZyVersa Therapeutics, Inc.
VAR 200 and IC 100
Zy Versa Therapeutics, Inc. is a clinical stage biopharmaceutical company developing products for renal and inflammatory diseases, including VAR 200 for focal segmental glomerulosclerosis and related conditions, and IC 100 as an ASC inhibitor for inflammatory diseases.
About | Vision/Values | Leadership | About | Directors | About | About | About | About | About | About | Contact | Careers | Careers | About | About | About
Symbol: ZVSA
Recent Price: $1.07
Industry: Biotechnology
CEO: Mr. Stephen C. Glover
Sector: Healthcare
Employees: 7
Address: 2200 N. Commerce Parkway, Weston, FL 33326
Phone: 754 231 1688
Leadership
- Stephen C. Glover, Chairman of the Board at Ambrx Biopharma
- Pablo A. Guzman, MD, FACC, Board of Directors member
- Karen Cashmere, Board of Directors member
- Peter Wolfe, Board of Directors member
- Robert (Rob) G. Finizio, Executive Director of PleoPharma
- GREGORY G. FREITAG, JD, CPA, Principal of FreiMc
- Minchul Park, Ph.D, Chief Executive Officer, and Director of Curebio Therapeutics, Adjunct Professor, Korea University, Department of Pharmacy
- JAMES SAPIRSTEIN, Chairman, Chief Executive Officer and President of First Wave Biopharma
- N/A, N/A
Last updated: 2024-12-31